IFF announced a significant expansion of its pet portfolio, aiming to revolutionize companion animal care through advanced biotechnology and innovation. The new portfolio empowers brands to address key challenges in pet health and wellness, delivering products that enhance gut health, dental care, hydration, and odor reduction.
Leveraging decades of expertise in human and animal wellness, IFF integrates flavors, functional technologies, processing aids, and ingredients into a cohesive ecosystem. The solutions are supported by specialized R&D centers, including the Pet Translational Research Lab, Pet Enzymes Lab, and Pet Applications Lab.
The newly launched solutions focus on enzyme-driven palatability with clean-label appeal, sustainable ingredients for cost-effective production, and functional health technologies for the full pet life cycle. This expansion positions IFF to meet the rising demand for smarter, more sustainable pet care across the U.S. market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.